Deanna L. Kelly | Psychiatrist.com

Original Research

Cardiovascular Disease Mortality in Patients With Chronic Schizophrenia Treated With Clozapine: A Retrospective Cohort Study

Original Research

Clozapine Use in Patients with Benign Neutropenia

Is clozapine safe for patients with benign neutropenia? Many patients with lower than normal absolute neutrophil count do not qualify for clozapine therapy or are at risk of having...

Original Research

Clozapine Utilization and Outcomes by Race in a Public Mental Health System: 1994-2000

Consensus Statement

Consensus on Monitoring Blood Antipsychotic Levels

The quantification of antipsychotic levels in blood, or therapeutic drug monitoring (TDM), could aid clinicians in numerous challenging scenarios. Learn more about using TDM for dosing decisions in this...

Original Research

A Dose-Outcome Analysis of Risperidone

Original Research

Prevalence of Bone Mineral Density Loss in Korean Patients With Schizophrenia: A Cross-Sectional Study

Original Research

A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia

Letter to the Editor

Six-Month Review of Weight and Metabolic Parameters in Patients Receiving Clozapine, Risperidone, Olanzapine, or Quetiapine

Original Research

Thyroid Function in Treatment-Resistant Schizophrenia Patients Treated With Quetiapine, Risperidone, or Fluphenazine

Letter to the Editor

Substance Use and Cannabis Withdrawal

Cannabis withdrawal symptoms are clinically significant because they may act as negative reinforcement for relapse to cannabis use. Here, the authors present data on psychoactive substance use before and...